ALMS as of Oct 31 · 23:41 ET
ALMSNasdaqPharmaceutical Preparations
Alumis Inc. · Brief
Next report
11 days
Nov 12 · after closeest.Q3 FY26
Expected move
No implied move.
0 of 7≥ implied
- avg implied
- ±23.3%
- avg realized
- ±6.2%
Mar 19 '25—▼−18.31%—
May 14 '25±33.3%▲+18.63%×0.56
Aug 13 '25±31.0%▼−0.68%×0.02
Q3 FY25±27.2%▲+4.55%×0.17
Jan 9 '26±10.1%▲+7.59%×0.75
Q1 FY26±20.4%▼−1.26%×0.06
May 14 '26±16.1%▼−7.15%×0.44
Q2 FY26±25.3%▲+3.69%×0.15
quarterimplied−35%0+35%realized×
Q2 FY26±25.3%▲+3.69%×0.15
May '26±16.1%▼−7.15%×0.44
Q1 FY26±20.4%▼−1.26%×0.06
Jan '26±10.1%▲+7.59%×0.75
Q3 FY25±27.2%▲+4.55%×0.17
Aug '25±31.0%▼−0.68%×0.02
2 older reports
May '25±33.3%▲+18.63%×0.56
Mar '25—▼−18.31%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 12 report · est.Bull2 of 4
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
ALMS report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.